NPDUIS Advisory Committee
Chair
Kevin Pothier
Manager, NPDUIS
Patented Medicine Prices Review Board
Members
Christine Voggenreiter
Director, Economic Analysis, Pharmaceutical Services Division
British Columbia Ministry of Health
Sandra
Rees
Pharmaceutical Policy Consultant, Pharmaceuticals and Health Benefits
Alberta
Health
Rachel Cheruvallath
Director, Pharmaceutical Policy and Appropriateness Unit, Drug Plan and Extended Benefits Branch
Saskatchewan
Ministry of Health
Patricia Caetano
Executive Director, Provincial Drug Programs
Manitoba Health
Angie Wong
Director, Drug Programs Policy and Strategy Branch, Drugs and Devices Division
Ontario Public Drug Programs
Erica Craig
Director, Provincial Pharmacy, Pharmaceutical Services
New Brunswick Department of Health
Charmaine Cooke
Manager, Drug Technology Assessment
Pharmaceutical Services and Extended Health Benefits
Bonnie Corish
Pharmacist Consultant, Pharmacare Program
Health Prince Edward Island
Marguerite
Mullins
Manager,
Client Services and Operations, Pharmaceutical Services Division
Newfoundland and Labrador Department of Health and Community Services
Shauna Demers
Director Insured Health Services
Yukon Department of Health and Social Services
Karen Fortin
Director, Pharmacy Policy Development Division, Non-Insured Health Benefits Directorate
Indigenous Services Canada
Andrea Gilpin
Senior Policy Advisor, Office of Pharmaceuticals Management
Strategies
Health
Canada
Observers
Tracey Fisher
Manager, Pharmaceuticals
Canadian Institute for Health Information
Dr. Nicole Mittmann
Chief Scientist and VP Evidence Standards
Canadian Agency for Drugs and Technologies in Health
Karen Lee
Director, Health Economics
Canadian Agency for Drugs and Technologies in Health
Dominic Bélanger
Acting Director, Direction des affaires pharmaceutiques et du médicament
Ministère de la Santé et des Services sociaux du Québec
Daniel Sperber
Senior Economist
pan-Canadian
Pharmaceutical Alliance Office
Renata Slivinski
CSPS Project Lead, Opioid Response Team
Health Canada